Who owns ENSYSCE BIOSCIENCES ORD?
- Ticker: ENSC
- CUSIP Number: 293602504
Tip: Access positions for across all investors
Analyze quarterly positions in Ensysce Biosciences Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ensysce Biosciences Ord stock
Who bought or sold ENSYSCE BIOSCIENCES ORD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Perceptive Advisors | 87k | $205k | 0% | Sep 2025 |
|
| Adage Capital Partners GP | 75k | $177k | 0% | Sep 2025 |
|
| DRW Holdings | 69k | $164k | 100% | Sep 2025 |
|
| Vanguard Group | 37k | $87k | 100% | Sep 2025 |
|
| Renaissance Technologies | 16k | $37k | 100% | Sep 2025 |
|
| Citadel Advisors | 15k | $34k | 100% | Sep 2025 |
|
| Virtu Financial | 14k | $34k | 100% | Sep 2025 |
|
| Geode Capital Management | 13k | $31k | 28% | Sep 2025 |
|
| XTX Topco | 11k | $26k | 100% | Sep 2025 |
|
| Tru Independence Asset Management 2 | 11k | $25k | 100% | Sep 2025 |
|
| FNY Investment Advisers | 3.0k | $6.0k | 0% | Jun 2025 |
|
| Tower Research Capital | 1.3k | $3.2k | -2% | Sep 2025 |
|
| UBS Group | 800.00 | $1.9k | 126% | Sep 2025 |
|
| SBI Securities | 418.00 | $990.994400 | -82% | Sep 2025 |
|
| Morgan Stanley | 378.00 | $843.015600 | 100% | Jun 2025 |
|
| BlackRock | 65.00 | $153.998000 | 0% | Sep 2025 |
|
| Assetmark | 13.00 | $30.999800 | 100% | Sep 2025 |
|
Who sold out of Ensysce Biosciences Ord?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Raymond James Financial | Jun 2025 | 94.00 | $209.996000 |